|
|
With pandemic-era enhancements set to expire, the future of remote medicine is in flux.
|
|
|
|
|
|
CRISPR-based treatments are poised to address serious diseases — but first there’s a problem to solve, says Nobel laureate Jennifer Doudna.
|
|
|
|
|
|
For one thing, it’s not a $5 billion checking account, explains chief financial officer Julie Joncas.
|
|
|
|
|
|
Shubhayu Bhattacharyay hopes to use computation to improve treatment of traumatic brain injury.
|
|
|
|
|
Acrylic painting by Irene Kolada, staff assistant in the Benoist-Mathis Lab in the Department of Immunology.
See
full post.
|
|
|
Published by Harvard Medical School, Office of Communications and External Relations
© 2024 The President and Fellows of Harvard College
|
|
|
|
|